Press Releases
Bristol Myers Squibb Rakes In Nearly $2B While Suing to Block Cost-Lowering Program
Pharmaceutical giant Bristol Myers Squibb announced $1.7 billion in Q2 2024 earnings today amid the company’s ongoing legal challenge to block the Biden-Harris administration from lowering medication costs for millions of Americans. The pharmaceutical giant is one of several companies appealing recent court rulings defending Medicare’s negotiation